# Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
Canonical URL: https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-reports-q1-2026-financial-results-and-provides-a-corporate-update
Ticker: UNH
Company: UnitedHealth Group
Source: UnitedHealth Group
Published: 2026-05-12 12:00 EST
Original Source URL: https://ir.corbuspharma.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-06 12:00 EST — [Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer](https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-appoints-leonardo-viana-nicacio-m-d-as-chief-medical-offi-7e9400c6) — Source: UnitedHealth Group
- 2026-05-26 11:00 EST — [Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers](https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-reports-updated-crb-701-phase-1-2-clinical-data-demonstrating-robust-activity-in-2l-oropharyngeal-and-cervical-cancers) — Source: UnitedHealth Group
- 2026-05-21 12:00 EST — [Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call](https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-announces-the-appointment-of-nishant-saxena-as-chief-business-officer-and-schedules-a-pre-2026-asco-crb-701-data-conference-call) — Source: UnitedHealth Group
- 2026-05-14 12:00 EST — [Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors](https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-appoints-pharma-industry-veteran-brent-pfeiffenberger-to-board-of-directors) — Source: UnitedHealth Group
- 2026-05-13 11:00 EST — [Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/UNH/corbus-pharmaceuticals-to-participate-in-upcoming-investor-conferences) — Source: UnitedHealth Group
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)